HUA Fang 1,2,3,4 , HE Hong 1,2
  • 1. The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School of Stomatology, Wuhan University, Wuhan, 430079, P.R.China;
  • 2. Department of Orthodontics, Hospital of Stomatology, Wuhan University, Wuhan, 430079, P.R.China;
  • 3. Center for Evidence-Based Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, P.R.China;
  • 4. Cochrane Oral Health Group, Division of Dentistry, The University of Manchester, Manchester, M13 9PL, UK;
HE Hong, Email: drhehong@whu.edu.cn
Export PDF Favorites Scan Get Citation

Within person trial is an efficient study design for randomized controlled trials which has been widely used in fields of dentistry, dermatology and ophthalmology. However, due to a series of inherent methodological difficulties, the design, conduct and reporting of within person trials usually requires additional methodological knowledge and considerations from researchers. To standardize and improve the reporting quality of these trials, the BMJ recently published the CONSORT statement extension for within person trials. The present article aimed to provide interpretation of this reporting guideline, and thereby promote its understanding and use among Chinese researchers.

Citation: HUA Fang, HE Hong. Interpretation of the Consolidated Standards of Reporting Trials (CONSORT) guideline for within person trials. Chinese Journal of Evidence-Based Medicine, 2018, 18(9): 1001-1006. doi: 10.7507/1672-2531.201804086 Copy

  • Next Article

    Interpretation and assessment of reporting guideline of systematic review/meta-analysis for diagnostic test accuracy study (PRISMA-DTA)